Lambo, Rogelio T.

HRN: 10-66-25  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/29/2025
06/09/2025
IV
500mg
Q12h
INTRAABDOMINAL INFECTION
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines